1,846
Participants
Start Date
March 31, 1995
Primary Completion Date
December 31, 2001
Study Completion Date
December 31, 2001
Standard dose, low flux hemodialysis
Standard dose, high flux hemodialysis
High dose, low flux hemodialysis
High dose, high flux hemodialysis
University of Rochester School of Medicine, Rochester
Collaborators (2)
University of Rochester
OTHER
The Cleveland Clinic
OTHER
Tufts Medical Center
OTHER
Vanderbilt University
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
OTHER
Washington University School of Medicine
OTHER
University of Illinois at Chicago
OTHER
Main Line Health
OTHER
Emory University
OTHER
Duke University
OTHER
University of Texas Southwestern Medical Center
OTHER
Brigham and Women's Hospital
OTHER
Wake Forest University Health Sciences
OTHER
University of Utah
OTHER
University of California, Davis
OTHER
University of Alabama at Birmingham
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH